Bionomics Statistics

Total Valuation

Bionomics has a market cap or net worth of $8.41 million. The enterprise value is -$458,495.

Market Cap	8.41M
Enterprise Value	-458,495

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Bionomics has 11.89 million shares outstanding. The number of shares has increased by 14.43% in one year.

Shares Outstanding	11.89M
Shares Change (YoY)	+14.43%
Shares Change (QoQ)	+1.23%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	17.90%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	560.73
Forward PS	n/a
PB Ratio	0.43
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.81, with a Debt / Equity ratio of 0.05.

Current Ratio	3.81
Quick Ratio	3.47
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-978.98

Financial Efficiency

Return on equity (ROE) is -80.80% and return on invested capital (ROIC) is -0.74%.

Return on Equity (ROE)	-80.80%
Return on Assets (ROA)	-65.20%
Return on Capital (ROIC)	-0.74%
Revenue Per Employee	$1,875
Profits Per Employee	-$2.64M
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Bionomics has paid $2,505 in taxes.

Income Tax	2,505
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.65% in the last 52 weeks. The beta is -0.11, so Bionomics's price volatility has been lower than the market average.

Beta (5Y)	-0.11
52-Week Price Change	-69.65%
50-Day Moving Average	0.87
200-Day Moving Average	1.46
Relative Strength Index (RSI)	40.84
Average Volume (20 Days)	174,187

Short Selling Information

Short Interest	388,297
Short Previous Month	76,134
Short % of Shares Out	3.27%
Short % of Float	n/a
Short Ratio (days to cover)	1.05

Income Statement

In the last 12 months, Bionomics had revenue of $14,998 and -$21.09 million in losses.

Revenue	14,998
Gross Profit	14,707
Operating Income	-150,066
Pretax Income	-20.68M
Net Income	-21.09M
EBITDA	n/a
EBIT	-20.66M
Earnings Per Share (EPS)	$33.38

Full Income Statement

Balance Sheet

The company has $9.92 million in cash and $1.05 million in debt, giving a net cash position of $8.87 million or $0.75 per share.

Cash & Cash Equivalents	9.92M
Total Debt	1.05M
Net Cash	8.87M
Net Cash Per Share	$0.75
Equity (Book Value)	19.37M
Book Value Per Share	1.63
Working Capital	8.29M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-17.77M
Capital Expenditures	n/a
Free Cash Flow	-17.77M
FCF Per Share	-$2.15

Full Cash Flow Statement

Margins

Gross margin is 98.06%, with operating and profit margins of -1,000.57% and -140,642.11%.

Gross Margin	98.06%
Operating Margin	-1,000.57%
Pretax Margin	-137,892.91%
Profit Margin	-140,642.11%
EBITDA Margin	n/a
EBIT Margin	-137,752.20%
FCF Margin	-118,490.14%

Dividends & Yields

Bionomics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.43%
Shareholder Yield	-14.43%
Earnings Yield	-250.82%
FCF Yield	-211.31%

Analyst Forecast

The average price target for Bionomics is $9.00, which is 1,172.09% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.00
Price Target Difference	1,172.09%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Bionomics has an Altman Z-Score of -9.35 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.35
Piotroski F-Score	2